| NCT ID | NCT07598669 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Primary Biliary Cholangitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-03-18 |
| Primary Completion | 2040-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2026-03-18 with a primary completion date of 2040-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this registry is to better understand how primary biliary cholangitis develops over time, including the role of disease-related biomarkers, complications of the disease, and symptom burden. Patients with primary biliary cholangitis treated at participating centres in Austria will be invited to take part in this prospective registry. Participation in an associated biobank is optional. Clinical and laboratory data will be collected, and patients will be followed regularly through scheduled clinic visits. In addition, biological samples (serum, plasma, and, if available, liver tissue) may be collected and stored in the biobank for future research.
Eligibility Criteria
Inclusion Criteria: * Age \>18 years * Confirmed diagnosis of primary biliary cholangitis (at least two of the following three criteria must be fulfilled: persistent elevation of alkaline phosphatase above the upper limit of normal for at least 6 months; presence of antimitochondrial antibodies or PBC-specific antinuclear antibodies; characteristic histopathology) * Written informed consent for participation in the registry Exclusion Criteria: * Withdrawal of written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07598669 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Primary Biliary Cholangitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07598669 currently recruiting?
Yes, NCT07598669 is actively recruiting participants. Contact the research team at Michael.Trauner@meduniwien.ac.at for enrollment information.
Where is the NCT07598669 trial being conducted?
This trial is being conducted at Klagenfurt, Austria, Sankt Pölten, Austria, Salzburg, Austria, Vienna, Austria and 7 additional locations.
Who is sponsoring the NCT07598669 clinical trial?
NCT07598669 is sponsored by Medical University of Vienna. The trial plans to enroll 500 participants.